Squarepoint’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $91.9M | Buy |
|
|||||
|
2025
Q1 | $98.2M | Buy |
|
|||||
|
2024
Q4 | $45.6M | Buy |
|
|||||
|
2024
Q3 | $14.4M | Buy |
|
|||||
|
2024
Q2 | $8.54M | Sell |
|
|||||
|
2024
Q1 | $75.2M | Buy |
|
|||||
|
2023
Q4 | $26.9M | Sell |
|
|||||
|
2023
Q3 | $40.4M | Buy |
|
|||||
|
2023
Q2 | $27.5M | Buy |
|
|||||
|
2023
Q1 | $16.7M | Sell |
|
|||||
|
2022
Q4 | $18.1M | Buy |
|
|||||
|
2022
Q3 | $2M | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $16.9M | Sell |
|
|||||
|
2021
Q4 | $22.7M | Buy |
|
|||||
|
2021
Q3 | $15.3M | Buy |
|
|||||
|
2021
Q2 | $7.41M | Sell |
|
|||||
|
2021
Q1 | $9.52M | Buy |
|
|||||
|
2020
Q4 | $5.06M | Buy |
|
|||||
|
2020
Q3 | $1.97M | Sell |
|
|||||
|
2020
Q2 | $8.59M | Sell |
|
|||||
|
2020
Q1 | $10.2M | Sell |
|
|||||
|
2019
Q4 | $30.7M | Buy |
|
|||||
|
2019
Q3 | $4.14M | Sell |
|
|||||
|
2019
Q2 | $10.2M | Buy |
|
|||||
|
2019
Q1 | $9.42M | Buy |
|
|||||
|
2018
Q4 | $360K | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $5.17M | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $259K | Sell |
|
|||||
|
2016
Q2 | $866K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $712K | Sell |
|
|||||
|
2015
Q3 | $800K | Buy |
|
|||||
|
2015
Q2 | – | Sell |
|
|||||
|
2015
Q1 | $897K | Buy |
|